BioNJ's Prestigious Speaker Roster for Eighth Annual C-Suite Summit

News provided by

Oct 13, 2020, 15:23 ET

TRENTON, N.J., Oct. 13, 2020 /PRNewswire/ -- BioNJ has released its final speaker roster featuring thought leaders from more than 20 leading biopharmaceutical organizations -- for its Eighth Annual C-Suite Summit, taking place virtually October 30 and November 6.

The C-Suite Summit brings together life sciences executives representing a wide breadth of companies from early to late stage, public and private and revenue and pre-revenue to discuss the topics impacting C-Suite decision-making in bringing new innovative treatments to market.

"In these unprecedented times, we felt it important to offer the life sciences community the opportunity to participate in this year's conference from the safety of your own personal workspace," said BioNJ President and CEO, Debbie Hart.

"The advent of COVID-19 has brought unimaginable global disruption and loss in ways never imagined. Our prestigious roster of industry experts -- many leading the way in the discovery of new cures and therapies to combat the Coronavirus -- will reflect upon observations, learnings and projections, as well as short- and long-term opportunities for medical innovation and the industry overall in light of the pandemic."

Live plenary sessions will feature these industry experts:

Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner, Acting CIO, FDA
Mike Davis, Head, U.S. Neurology, UCB
Kevin Bitterman, Ph.D., Partner, Atlas Ventures
Michele Buenafe, Partner, Morgan, Lewis & Bockius LLP
Chris Cozic, Corporate Vice President, Global HR, Genmab
Bruce A. Feinberg - DO, Vice President of Clinical Affairs and Chief Medical Officer, Cardinal Health Specialty Solutions
Laura Furstenthal, Ph.D., Senior Partner, McKinsey & Company
Daniel Garen, Partner, DLA Piper
Anupam Girdhar, Vice President and General Manager, Clinical Vertical - Genetic Sciences Division, Thermo Fisher Scientific
Greg Graves, Partner, McKinsey & Company
Debbie Hart, President & CEO, BioNJ
Derek Hicks, Senior Vice President/Head of Business Development, Spark Therapeutics
Jamie Johnson, Director, Human Resources, Insmed
Jack Levitt, Co-Founder & Principal, LeaderStrong
Daniel Lochner, CFO, Oyster Point Pharma
Michelle McMurry-Heath, M.D., Ph.D., President & CEO, BIO
Innes Meldrum, SVP & Chief Commercial Officer, Otsuka
Johanna Mercier, Chief Commercial Officer, Gilead
Elizabeth Mily, EVP, Head of Strategy and Business Development, Bristol Myers Squibb
Francois Nader, M.D., Board Director, Moderna
Patricia Obermaier, Vice President, U.S. Health & Life Sciences, Microsoft
Elaine O'Hara, Head of North America Commercial Operations, Sanofi Pasteur
Michele Oshman, Vice President, External Relations, BIO
Martin Rexroad, Sr. Vice President, HR & Administration, PTC Therapeutics
Liad Samir, Sr. Manager, Talent Acquisition, Leo Pharma
Linda Schwimmer, President and CEO, New Jersey Health Care Quality Institute
Nicolette Sherman, Chief Human Resources Officer, Oyster Point Pharma
Arda Ural, Ph.D., Americas Industry Markets Leader - Life Sciences & Healthcare, EY
David Wasserman, U.S. House Editor, Cook Political Report
Dave Williams, Chief Information & Digital Officer, Merck & Co.
Tal Zaks, M.D., Chief Medical Officer, Moderna

Topics to be discussed:

Innovation and New World Order - Stepping Back and Looking Forward
Industry on the Forefront
The Regulatory Horizon
Navigating Innovation & Uncertainty from the Top
Returning to the Office
The Financial Environment
COVID-19 - Driven Technology Transformation and the Patient
Data Analytics and Solving for the Future
The "New Normal" - Transition, Recovery and Beyond
Virtual Meetup with David Wasserman

Registration is $250 for BioNJ Members and $350 for Future BioNJ Members. BioNJ Member Companies can purchase 3 or more registrations for the reduced price of $575. Contact Kim Minton at [email protected] to learn about Sponsorship opportunities.

Contact
Randi Bromberg
Vice President, Communications and Marketing
O) 609-890-3185
C) 609-955-1067
[email protected]

SOURCE BioNJ